What We're Reading
Industry reads hand-picked by our editors
Jun 18, 2021
-
Timmerman Report
On Juneteenth, Honoring 22 Black Biotech Leaders
-
The Washington Post
How Pfizer engineers overcame early obstacles to produce 3 billion shots
-
STAT
Athira Pharma CEO placed on leave amid claims of altered images
-
Reuters
CureVac may let contractors make rival vaccines if own shot fails - CEO
Jun 17, 2021
-
The New York Times
Vaccine Maker Earned Record Profits but Delivered Disappointment in Return
-
Endpoints News
Danaher strikes deal to buy booming next-gen manufacturer Aldevron for $9.6B
-
Bloomberg
New York Push to Rein In Drug Plans Tests High Court Ruling
-
CNBC
Novartis CEO says future pandemics are bound to happen. Here's how to prepare for the next one
-
Healthcare Dive
Supreme Court upholds ACA in 7-2 decision, leaving intact landmark US health law
Jun 16, 2021
-
Reuters
First patient set to receive controversial Biogen Alzheimer's drug
-
The Wall Street Journal
Lina Khan, Critic of Large Tech Firms, to Lead Federal Trade Commission
-
The Boston Globe
Life sciences is poised to be Boston's dominant industry. Has the area become the Silicon Valley of biotech?
-
In The Pipeline
The Novavax Vaccine Data, and Spike Proteins in General
Jun 15, 2021
-
Axios
Health care CEO pay soars during pandemic
-
Bloomberg Law
Divisive Drug Patent Proposal From Trump Era Is on Biden Agenda
-
The Wall Street Journal
AstraZeneca Covid-19 Antibody Treatment Suffers Setback
Jun 14, 2021
-
The New York Times
What the C.E.O. of Pfizer and Other Covid-19 Fighters Learned From Their Parents
-
STAT
Alzheimer's Association blasts Biogen over price of new drug Aduhelm
-
Timmerman Report
Biotech Pride: 19 Industry Leaders Who Identify as LGBTQ
-
Health Affairs
The FDA’s Approval Of Aduhelm: Potential Implications Across A Wide Range Of Health Policy Issues And Stakeholders
Jun 11, 2021
-
POLITICO
Controversial drug approval stokes concern about lack of a permanent FDA chief
-
Associated Press
US extends expiration dates for J&J COVID vaccine by 6 weeks
-
STAT
Advocates blast the FDA for not moving as fast on ALS as on Alzheimer’s
-
Kaiser Health News
Change to Gilead Assistance Program Threatens PrEP Access, HIV Advocates Say
Jun 10, 2021
-
The Wall Street Journal
U.S. to Donate 500 Million Covid-19 Vaccine Doses to Lower-Income Countries
-
Bloomberg
Biogen Faces Democrats' Ire Over Price Tag for Alzheimer's Drug
-
The New York Times
What I Learned in 33 Years at the C.D.C.
-
FiercePharma
Regeneron's CEO, CSO pay under fire from advisory firms, who call on shareholders to oust a board member
